カテゴリー： IMARC, 世界, 医療/バイオ

小児用ワクチンの世界市場2022-2028：産業動向、シェア、規模、成長、機会・予測

◆英語タイトル：Pediatric Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが発行した調査報告書（IMARC23FE0099）◆商品コード：IMARC23FE0099
◆発行会社（リサーチ会社）：IMARC
◆発行日：2023年2月1日
◆ページ数：145
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥759,848見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

IMARC社発行の当調査資料によると、2022年342億ドルであった世界の小児用ワクチン市場規模が2028年には549億ドルに達し、予測期間中、年平均8.1％成長すると予測されています。当書は、小児用ワクチンの世界市場について総合的に調査・分析されたレポートです。序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、種類別（多価、一価）分析、技術別（コンジュゲート、ライブアテニュエート、不活性化、サブユニット、その他）分析、用途別（感染症、がん、アレルギー、その他）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東/アフリカ）分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目がまとめられています。なお、当書に掲載されている企業情報には、Abbott Laboratories、Bio-Med Private Limited、Daiichi Sankyo Company Limited、GSK plc、Indian Immunologicals Limited (National Dairy Development Board)、Merck & Co. Inc.、Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)、Panacea Biotec Limited、Pfizer Inc.、Sanofi S.A. and Sinovac Biotech Ltd.などが含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション

・世界の小児用ワクチン市場規模：種類別
- 多価の市場規模
- 一価の市場規模

・世界の小児用ワクチン市場規模：技術別
- コンジュゲートの市場規模
- ライブアテニュエートの市場規模
- 不活性化の市場規模
- サブユニットの市場規模
- その他技術の市場規模

・世界の小児用ワクチン市場規模：用途別
- 感染症における市場規模
- がんにおける市場規模
- アレルギーにおける市場規模
- その他用途における市場規模

・世界の小児用ワクチン市場規模：地域別
- 北米の小児用ワクチン市場規模
- アジア太平洋の小児用ワクチン市場規模
- ヨーロッパの小児用ワクチン市場規模
- 中南米の小児用ワクチン市場規模
- 中東/アフリカの小児用ワクチン市場規模

・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競争状況
・主要企業情報

The global pediatric vaccines market size reached US$ 34.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 54.9 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028.

Pediatric vaccines or immunizations refer to medical supplies that create immunity in infants, children and adolescents. They are utilized for the prevention, treatment and management of diseases and are commonly available in multivalent and monovalent variants. These vaccines are commonly used in pediatric oncology, cardiology, critical care, and pulmonology departments. Pediatric vaccines assist in protecting children from various serious illnesses, such as polio, measles, brain swelling, paralysis, diarrhea and hepatitis. These vaccines are safe, effective, promote a healthier life and protect against infectious or noninfectious diseases.

Pediatric Vaccines Market Trends:
The increasing number of births and the rising prevalence of various pediatric diseases represents the key factor primarily driving market growth. Additionally, the increasing need to promote public health and the widespread adoption of pediatric vaccines as a cost-effective means of advancing global welfare is also propelling the market growth. In line with this, the development of efficacious and safe vaccination that eliminates and decreases dangerous diseases that spread from child to child is favoring the market growth. Furthermore, various product innovations, such as the introduction of new pediatric vaccines that aid in the treatment of adolescents and children with relapsing forms of multiple sclerosis (RMS), are providing a considerable boost to the market growth. Additionally, the increasing demand for conjugate vaccines that consist of antigens and have the ability to elicit immunological memory and reduce asymptomatic carriage of the bacteria is positively impacting the market growth. Apart from this, growing awareness regarding early disease diagnosis and prevention, extensive research and development (R&D) activities and implementation of various government initiatives to promote accurate and timely administration of pediatric vaccination are anticipated to drive the market further toward growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global pediatric vaccines market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, technology and application.

Breakup by Type:

Multivalent
Monovalent

Breakup by Technology:

Conjugate
Live Attenuated
Inactivated
Subunit
Toxoid
Others

Breakup by Application:

Infectious Disease
Cancer
Allergy
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bio-Med Private Limited, Daiichi Sankyo Company Limited, GSK plc, Indian Immunologicals Limited (National Dairy Development Board), Merck & Co. Inc., Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation), Panacea Biotec Limited, Pfizer Inc., Sanofi S.A. and Sinovac Biotech Ltd.

Key Questions Answered in This Report:
How has the global pediatric vaccines market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global pediatric vaccines market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global pediatric vaccines market and who are the key players?
What is the degree of competition in the industry?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Pediatric Vaccines Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Multivalent
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Monovalent
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Technology
7.1 Conjugate
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Live Attenuated
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Inactivated
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Subunit
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Toxoid
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Application
8.1 Infectious Disease
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cancer
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Allergy
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Bio-Med Private Limited
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Daiichi Sankyo Company Limited
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 GSK plc
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Indian Immunologicals Limited (National Dairy Development Board)
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Merck & Co. Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.8 Panacea Biotec Limited
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Pfizer Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Sanofi S.A.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Sinovac Biotech Ltd.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 小児用ワクチンの世界市場2022-2028：産業動向、シェア、規模、成長、機会・予測(Pediatric Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • アルツハイマー病治療薬の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • 高脂血症治療薬の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • 血液悪性腫瘍の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • 抗感染症薬の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測
  • デジタル定量吸入器の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測

    • ◆H&Iグローバルリサーチのお客様（例）◆